Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114962

Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

C Serradeil-Le Gal, C Jouneaux, A Sanchez-Bueno, D Raufaste, B Roche, A M Préaux, J P Maffrand, P H Cobbold, J Hanoune, and S Lotersztajn

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Serradeil-Le Gal, C. in: JCI | PubMed | Google Scholar

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Jouneaux, C. in: JCI | PubMed | Google Scholar

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Sanchez-Bueno, A. in: JCI | PubMed | Google Scholar

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Raufaste, D. in: JCI | PubMed | Google Scholar

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Roche, B. in: JCI | PubMed | Google Scholar

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Préaux, A. in: JCI | PubMed | Google Scholar

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Maffrand, J. in: JCI | PubMed | Google Scholar

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Cobbold, P. in: JCI | PubMed | Google Scholar

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Hanoune, J. in: JCI | PubMed | Google Scholar

Sanofi Recherche, Biochimie Exploratoire, Toulouse, France.

Find articles by Lotersztajn, S. in: JCI | PubMed | Google Scholar

Published January 1, 1991 - More info

Published in Volume 87, Issue 1 on January 1, 1991
J Clin Invest. 1991;87(1):133–138. https://doi.org/10.1172/JCI114962.
© 1991 The American Society for Clinical Investigation
Published January 1, 1991 - Version history
View PDF
Abstract

High affinity binding sites for endothelin (ET) were identified on rat liver plasma membranes. Binding of 125I-ET-1 with its site was specific, saturable, and time dependent (kobs = 0.019 +/- 0.001 min-1), but dissociation of receptor-bound ligand was minimal. A single class of high affinity binding sites for 125I-ET-1 was identified with an apparent Kd of 32.4 +/- 9.8 pM and a Bmax of 1084 +/- 118 fmol/mg protein. ET-3 and big-ET-1 (1-38) (human) inhibited 125I-ET-1 binding with IC50 values of 1.85 +/- 1.03 nM and 43 +/- 6 nM, respectively. Aequorin measurements of cytosolic free Ca2+ in single, isolated rat hepatocytes showed that ET-1 at subnanomolar concentrations induced a series of repetitive, sustained Ca2+ transients. ET-1 had no effect on cAMP production. Finally, ET-1 caused a rapid and sustained stimulation of glycogenolysis in rat hepatocytes. A 1.8-fold maximal increase in glycogen phosphorylase alpha was observed at 1 pM ET-1, with an EC50 of 0.03 pM. Stimulation of the enzyme was specific for ET-1 since the order of potency of related peptides was similar to that in binding experiments (ET-1 greater than ET-3 greater than big ET-1). These data constitute the first demonstration of the presence of ET-1 binding sites in liver which is associated with a rise in cytosolic free Ca2+ and a potent glycogenolytic effect. We conclude that ET-1 behaves as a typical Ca2+ mobilizing hormone in liver.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 133
page 133
icon of scanned page 134
page 134
icon of scanned page 135
page 135
icon of scanned page 136
page 136
icon of scanned page 137
page 137
icon of scanned page 138
page 138
Version history
  • Version 1 (January 1, 1991): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts